Elevated pulmonary dead space and coagulation abnormalities suggest lung microvascular thrombosis in patients undergoing cardiac surgery
- 91 Downloads
Inflammation has been shown to trigger microvascular thrombosis. Patients undergoing cardiac surgery sustain significant inflammatory insults to the lungs and in addition are routinely given anti-fibrinolytic agents to promote thrombosis. In view of these risk factors we investigated if evidence of pulmonary microvascular thrombosis occurs following cardiac surgery and, if so, whether a pre-operative heparin infusion may limit this.
Double-blind randomised controlled trial.
Tertiary university affiliated hospital.
Twenty patients undergoing elective cardiac surgery.
Patients were randomised to receive a pre-operative heparin infusion or placebo. All patients were administered aprotinin.
Measurements and results
Pulmonary microvascular obstruction was estimated by measuring the alveolar dead-space fraction. Pulmonary coagulation activation was estimated by measuring the ratio of prothrombin fragment levels in radial and pulmonary arterial blood. Systemic tissue plasminogen activator (t-PA) levels were also assessed. In the placebo group cardiac surgery triggered increased alveolar dead-space fraction levels and the onset of prothrombin fragment production in the pulmonary circulation. Administration of pre-operative heparin was associated with a lower alveolar dead-space fraction (p < 0.05) and reduced prothrombin fragment production in the pulmonary circulation (p < 0.05). Pre-operative heparin also increased baseline t-PA levels (p < 0.05).
The changes in the alveolar dead-space fraction and pulmonary coagulation activation suggest that pulmonary microvascular thrombosis develops during cardiac surgery and this may be limited by a pre-operative heparin infusion.
KeywordsCardiopulmonary bypass Coagulation Fibrinolysis Inflammation Thrombosis
- 4.Schlensak C, Doenst T, Preusser S, Wunderlich M, Kleinschmidt M, Beyersdorf F (2001) Bronchial artery perfusion during cardiopulmonary bypass does not prevent ischemia of the lung in piglets: assessment of bronchial artery blood flow with fluorescent microspheres. Eur J Cardiothorac Surg 19:326–331PubMedCrossRefGoogle Scholar
- 11.Dosquet C, Weill D, Wautier JL (1995) Cytokines and thrombosis. J Cardiovasc Pharmacol Suppl 25(2):S13–S19Google Scholar
- 12.Blume ED, Nelson DP, Gauvreau K, Walsh AZ, Plumb C, Neufeld EJ, Hickey PR, Mayer JE, Newburger JW (1997) Soluble adhesion molecules in infants and children undergoing cardiopulmonary bypass. Circulation 96:II-352–357Google Scholar
- 16.Pinsky DJ, Liao H, Lawson CA, Yan SF, Chen J, Carmeliet P, Loskutoff DJ, Stern DM (1998) Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. J Clin Invest 102:919–928PubMedCrossRefGoogle Scholar
- 25.Cooper JR Jr, Abrams J, Frazier OH, Radovancevic R, Radovancevic B, Bracey AW, Kindo MJ, Gregoric ID (2006) Fatal pulmonary microthrombi during surgical therapy for end-stage heart failure: possible association with antifibrinolytic therapy. J Thorac Cardiovasc Surg 131:963–968PubMedCrossRefGoogle Scholar
- 33.Nunn JF (1977) Respiratory dead space. In: Applied respiratory physiology, 2nd edn. Butterworths, LondonGoogle Scholar